Byondis Appoints Christoph Korpus, PhD, MBA as Chief Executive Officer
Christoph has played a pivotal role in shaping the Company’s strategic transformation since his appointment as Chief Business Officer in January 2025 Company Founder Jacques Lemmens, PhD, remains as Chairman of the Board NIJMEGEN, The Netherlands — Byondis B.V., an independent biopharmaceutical company creating innovative targeted medicines for patients with cancer, announces today the appointment […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.